Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAvon Protection Regulatory News (AVON)

Share Price Information for Avon Protection (AVON)

Share Price is delayed by 15 minutes
Get Live Data
1,660.00    6.00 (0.36%)
Bid:
1,654.00
Ask:
1,662.00
Spread: 8.00 (0.484%)
Market Cap: £488.90m
AVON Live PriceLast checked at - London Stock Exchange

Intraday Avon Protection Share Chart

AGM & Q1 Trading Update

30 Jan 2026 07:00

RNS Number : 0010R
Avon Technologies Plc
30 January 2026
Β 

30 January 2026 FOR IMMEDIATE RELEASE

​

Β 

Β 

AVON TECHNOLOGIES PLC

("Avon" or "the Group")

Β 

AGM & Q1 Trading Update

Β 

Continued strong demand. Full year guidance unchanged

Β 

Avon Technologies plc issues a trading update for the first quarter of the 2026 financial year ("Q1"), ahead of the Group's Annual General Meeting ("AGM"), which will be held at its Melksham facility at 10:30am today.

Β 

Avon Protection has continued its positive momentum with a record start to the year supported by sustained demand for our CBRN (Chemical, Biological, Radiological, and Nuclear) protection products, good operational gearing and a healthy order book and sales pipeline.

Β 

Team Wendy maintains a strong order book but saw a slower first quarter. The U.S. government shutdown delayed product testing and deliveries, which contributed to lower‑than‑expected Department of War and federal revenue in Q1. Margin was also held back by the planned increase in investment ahead of ramping production rates in Q2. Assuming no further extended government shutdowns, we expect these impacts to be temporary, with higher revenue, unwind of higher inventories and improved operational gearing expected over the remainder of the year.

Β 

At the Group level, we continue to anticipate full year performance consistent with the guidance provided at FY25 results in November, underpinned by continued robust demand for the Group's protective technologies.

Β 

Β 

Jos Sclater, Chief Executive Officer, commented:

"The first phase of our strategy to enhance operational performance through continuous improvement continues to deliver a stronger, more sustainable business. While there is still a lot to do to improve operational efficiency and productivity in our Cleveland facility, the momentum and capability we have built in our people is clear, we are making progress.

Β 

Having stabilised, strengthened and transformed Avon over the last three years, 2026 will see an increased focus on the growth stage of our strategy. We are investing across key programmes and new products that will strengthen our competitive position and expand our addressable markets. We are already seeing some promising early results.

Β 

We remain on track to meet or exceed our FY26 financial targets and look forward to sharing the next phase of our strategic development alongside our Interim and Full Year results."

Β 

AGM Presentation and Interim Results date

A presentation covering our recent continuous improvement activities and product innovation will be held at the AGM and will be available on our website later today: www.avon-technologiesplc.com

Β 

Avon will report Interim Results for the six months ending 31 March 2026 on 13 May 2026.

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

For further enquiries, please contact:

Avon Technologies plc

Jos Sclater, Chief Executive Officer

Rich Cashin, Chief Financial Officer investor.relations@avon-technologiesplc.com

Gabriella Colley, Corporate Affairs Director +44 7891 206 239

Sodali & Co

Pete Lambie avontechnologies@sodali.com

Tilly Abraham +44 7855 432 699

Β 

Β 

About Avon Technologies plc:

Avon Technologies is a Military and Law Enforcement protective equipment specialist. Our products are trusted to protect over 4 million service personnel and first responders in over 70 markets around the world.

Β 

Driven by a culture ofβ€―continuous improvement, we empower every individual in our organisation to identify opportunities and implement meaningful change. This commitment fuels our innovation and ensures we're constantly advancing our mission: to provide unparalleled protection for those who protect us.Β 

Β 

Our business is structured around two Strategic Business Units:Β 

Β· Avon Protection: a leading provider of advanced respiratory and integrated CBRN protective systems.Β 

Β· Team Wendy: a specialist in high-performance ballistic and impact protection helmet systems.Β 

Β 

For further information, please visit our websiteβ€―www.avon-technologiesplc.comΒ 

Legal Entity Identifier: 213800JM1AN62REBWA71Β 

Β 

Β 

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
TSTBLMLTMTJTBPF
Date   Source Headline
13th May 20267:00 amRNSInterim Results
8th May 20267:00 amRNSHolding(s) in Company
6th May 20262:03 pmRNSDirector/PDMR Shareholding
28th Apr 20267:00 amRNSHolding(s) in Company
14th Apr 20267:00 amRNSNotice of Results and Investor Presentation
8th Apr 202612:15 pmRNSHolding(s) in Company
8th Apr 202611:47 amRNSDirector/PDMR Shareholding
27th Mar 20261:23 pmRNSDirector/PDMR Shareholding
6th Mar 20261:23 pmRNSDirectors'/PDMR Shareholdings
6th Mar 20267:00 amRNSNew Filter Order
3rd Mar 20262:34 pmRNSHolding(s) in Company
13th Feb 202611:01 amRNSDirector/PDMR Shareholding
6th Feb 20262:52 pmRNSDirectors'/PDMR Shareholdings
6th Feb 20262:41 pmRNSFinal Dividend Currency Exchange Rate
4th Feb 20264:18 pmRNSHolding(s) in Company
2nd Feb 202610:10 amRNSResult of AGM
30th Jan 20267:00 amRNSAGM & Q1 Trading Update
20th Jan 20263:19 pmRNSDirector/PDMR Shareholding
6th Jan 20261:46 pmRNSDirectors'/PDMR Shareholdings
23rd Dec 20259:21 amRNSDirector/PDMR Shareholding
23rd Dec 20259:21 amRNSDirector/PDMR Shareholding
16th Dec 20258:45 amRNSHolding(s) in Company
11th Dec 20253:51 pmRNSHolding(s) in Company
11th Dec 20257:00 amRNSEuropean FM50 Order
9th Dec 202511:58 amRNSDirectors'/PDMR Shareholding
8th Dec 20251:32 pmRNSDirectors'/PDMR Shareholdings
5th Dec 20259:00 amRNSNotice of Annual Report & Accounts and AGM 2026
1st Dec 20256:01 pmRNSDirector Declaration
25th Nov 20253:55 pmRNSHolding(s) in Company
21st Nov 20259:50 amRNSNotification of LTIP & DSBP Awards
12th Nov 20257:00 amRNSPreliminary Results
7th Nov 20259:23 amRNSDirectors'/PDMR Shareholdings
16th Oct 20257:00 amRNSNotice of Results & Investor Presentation via IMC
8th Oct 202510:06 amRNSDirectors'/PDMR Shareholding
15th Sep 20252:51 pmRNSHolding(s) in Company
11th Sep 20254:10 pmRNSHolding(s) in Company
8th Sep 20251:14 pmRNSDirectors'/PDMR Shareholding
13th Aug 20254:59 pmRNSInterim Dividend Currency Exchange Rate
11th Aug 20254:47 pmRNSHolding(s) in Company
7th Aug 20253:10 pmRNSDirectors'/PDMR Shareholdings
17th Jul 20257:00 amRNSDirectors'/PDMR Shareholdings
23rd Jun 20257:00 amRNSUK MoD respirator order for Ukraine
10th Jun 20257:00 amRNSHolding(s) in Company
9th Jun 20259:30 amRNSDirectors'/PDMR Shareholdings
5th Jun 20253:31 pmRNSUS Department of Defense Order
3rd Jun 20256:00 pmRNSRenewi
29th May 202510:00 amRNSHolding(s) in Company
21st May 20257:00 amRNSInterim Results
20th May 20254:00 pmRNSNotification of change in particulars of director
16th May 20253:00 pmRNSNotification of change in particulars of director

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.